Postprandial Effect of Breakfast Glycemic Index on Vascular Function, Insulinemia and Cognitive Performance (BGI Study) (BGI)

Postprandial Effect of Breakfast Glycemic Index on Vascular Function, Insulinemia and Cognitive Performance, a Crossover Clinical Trial (BGI Study)

This is a crossover clinical trial aimed at adults (aged 20-40 years, with no cardiovascular disease), selected by consecutive sampling at urban primary care health clinics in Salamanca (Spain). Each subject will complete three interventions, with a washout period of one week: control breakfast (water), low glycemic index breakfast (apple, yogurt, walnuts and black chocolate) and high glycemic index breakfast (grape juice, bread and strawberry jam). The postprandial effect will be assessed at 60 and 120 minutes from each breakfast, measuring blood glucose and insulin and cognitive performance. Measurements will be performed of central blood pressure, augmentation index, pulse wave velocity, cardiac output and total peripheral vascular resistance at minutes (-10, 0, +15, +30, +45, +60, +75, +90, +105 and +120).

Study Overview

Detailed Description

Objectives:

The primary objective of this study is to evaluate the postprandial effect of low and high glycemic index breakfasts on vascular function, measured by central blood pressure, augmentation index and pulse wave velocity, in a sample of healthy young adults. The second objective is to assess the postprandial effect of low and high glycemic index breakfasts on blood glucose and insulin values in a sample of healthy young adults. The third and last objective is to assess the postprandial effect of low and high glycemic index breakfasts on cognitive performance in a sample of healthy young adults.

Design and setting:

A controlled crossover clinical trial, where each subject will complete three interventions (control breakfast, high glycemic index breakfast and low glycemic index breakfast), with a washout period of one week between each, and whose order will be determined by a randomization sequence generated using the Randomization.com software (http://www.randomization.com).

Study setting:

The study will be conducted in the primary care health area of Salamanca in the Research Unit of La Alamedilla, belonging to the Spanish Network for Preventive Activities and Health Promotion (redIAPP) and Salamanca Institute for Biomedical Research (IBSAL).

Study population:

The subjects of the study population will be selected by consecutive sampling in the primary care clinics of urban health centers in Salamanca (Spain) between 2015 and 2016. As this crossover clinical trial, a consecutive sampling will ensure comparability of the groups.

Intervention:

Each of the three scheduled visits will last approximately 2 and a half hours, and will be structured as follows:

Min -10: Measurement of clinical blood pressure, central blood pressure, and central hemodynamic parameters; evaluation of cognitive performance; laboratory test sampling to determine glucose and insulin blood levels.

Min 0: Measurement of central blood pressure and central hemodynamic parameters; intake of assigned breakfast (10 minutes).

Min +15, +30, +45: Measurement of central blood pressure and central hemodynamic parameters.

Min +60: Measurement of central blood pressure and central hemodynamic parameters; evaluation of cognitive performance; laboratory test sampling to determine glucose and insulin blood levels.

Min +75, +90, +105: Measurement of central blood pressure and central hemodynamic parameters.

Min +120: Measurement of central blood pressure and central hemodynamic parameters; evaluation of cognitive performance; laboratory test sampling to determine glucose and insulin blood levels.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Salamanca, Spain, 37003
        • Primary Care Research Unit - The Alamedilla Center for Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Young adults.
  • Aged between 20 and 40 years.
  • Both sexes.
  • Those agree to sign the informed consent.

Exclusion Criteria:

  • History of cardiovascular events (acute myocardial infarction, stroke, etc.).
  • History of hypertension, diabetes mellitus or dyslipidemia.
  • Pharmacological treatment for any of the above conditions.
  • Diagnosis of clinically demonstrable neurological and/or neuropsychological disease.
  • Excessive consumption of toxic substances.
  • Celiac patients and/or those intolerant to lactose.
  • Subjects on a low-calorie and/or low-sodium diet.
  • Pregnant women.
  • Those with any other circumstance that the investigators consider could interfere with the study procedures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control
Control breakfast
It consists of 350 ml of water at room temperature.
Other Names:
  • BF-1
It consists of 350 ml of water at room temperature, 200 ml of grape juice (with 136.28 kcal), 40 g of white bread (2 slices of 52.2 kcal each) and 29 g of strawberry jam (with 127.52 kcal); providing a total of 368.2 kcal.
Other Names:
  • BF-2
It consists of 350 ml of water at room temperature, a 150 g apple (with 81.12 kcal), a 125 g low-fat natural yogurt (with 56.10 kcal), 3 shelled walnuts (with 38.94 kcal per unit) and 17.5 g of 72% black chocolate (with 102 kcal); supplying a total of 356.04 kcal.
Other Names:
  • BF-3
Experimental: Intervention 1
High glycemic index breakfast
It consists of 350 ml of water at room temperature.
Other Names:
  • BF-1
It consists of 350 ml of water at room temperature, 200 ml of grape juice (with 136.28 kcal), 40 g of white bread (2 slices of 52.2 kcal each) and 29 g of strawberry jam (with 127.52 kcal); providing a total of 368.2 kcal.
Other Names:
  • BF-2
It consists of 350 ml of water at room temperature, a 150 g apple (with 81.12 kcal), a 125 g low-fat natural yogurt (with 56.10 kcal), 3 shelled walnuts (with 38.94 kcal per unit) and 17.5 g of 72% black chocolate (with 102 kcal); supplying a total of 356.04 kcal.
Other Names:
  • BF-3
Experimental: Intervention 2
Low glycemic index breakfast
It consists of 350 ml of water at room temperature.
Other Names:
  • BF-1
It consists of 350 ml of water at room temperature, 200 ml of grape juice (with 136.28 kcal), 40 g of white bread (2 slices of 52.2 kcal each) and 29 g of strawberry jam (with 127.52 kcal); providing a total of 368.2 kcal.
Other Names:
  • BF-2
It consists of 350 ml of water at room temperature, a 150 g apple (with 81.12 kcal), a 125 g low-fat natural yogurt (with 56.10 kcal), 3 shelled walnuts (with 38.94 kcal per unit) and 17.5 g of 72% black chocolate (with 102 kcal); supplying a total of 356.04 kcal.
Other Names:
  • BF-3

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Augmentation index
Time Frame: Changes in augmentation index at 1 week, according to glycemic index of the breakfast
Measurement by Mobil-O-Graph® device
Changes in augmentation index at 1 week, according to glycemic index of the breakfast

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Central blood pressure
Time Frame: Changes in central blood pressure at 1 week, according to glycemic index of the breakfast
Measurement by Mobil-O-Graph® device
Changes in central blood pressure at 1 week, according to glycemic index of the breakfast
Pulse wave velocity
Time Frame: Changes in pulse wave velocity at 1 week, according to glycemic index of the breakfast
Measurement by Mobil-O-Graph® device
Changes in pulse wave velocity at 1 week, according to glycemic index of the breakfast
Blood glucose
Time Frame: Changes in blood glucose at 1 week, according to glycemic index of the breakfast
Measurement by laboratory test sampling
Changes in blood glucose at 1 week, according to glycemic index of the breakfast
Insulin values
Time Frame: Changes in insulin values at 1 week, according to glycemic index of the breakfast
Measurement by laboratory test sampling
Changes in insulin values at 1 week, according to glycemic index of the breakfast
Immediate verbal memory
Time Frame: Changes in immediate verbal memory at 1 week, according to glycemic index of the breakfast
Assessment by immediate recall of a list of 15 words, in three attempts
Changes in immediate verbal memory at 1 week, according to glycemic index of the breakfast
Delayed verbal memory
Time Frame: Changes in delayed verbal memory at 1 week, according to glycemic index of the breakfast
Assessment by free recall of the words learnt in the first part of the study after a period of approximately 10 minutes
Changes in delayed verbal memory at 1 week, according to glycemic index of the breakfast
Phonological fluency
Time Frame: Changes in phonological fluency at 1 week, according to glycemic index of the breakfast
Assessment by enumerating for one minute as many words as possible starting with different letters
Changes in phonological fluency at 1 week, according to glycemic index of the breakfast
Attention
Time Frame: Changes in attention at 1 week, according to glycemic index of the breakfast
Assessment by Trail Making Test A
Changes in attention at 1 week, according to glycemic index of the breakfast
Processing speed
Time Frame: Changes in processing speed at 1 week, according to glycemic index of the breakfast
Assessment by Trail Making Test B
Changes in processing speed at 1 week, according to glycemic index of the breakfast
Executive functions
Time Frame: Changes in executive functions at 1 week, according to glycemic index of the breakfast
Assessment by Trail Making Test B
Changes in executive functions at 1 week, according to glycemic index of the breakfast
Working memory
Time Frame: Changes in working memory at 1 week, according to glycemic index of the breakfast
Assessment by WAIS Digit Span Backward test
Changes in working memory at 1 week, according to glycemic index of the breakfast
Sustained attention
Time Frame: Changes in sustained attention at 1 week, according to glycemic index of the breakfast
Assessment by Stroop test
Changes in sustained attention at 1 week, according to glycemic index of the breakfast
Selective attention
Time Frame: Changes in selective attention at 1 week, according to glycemic index of the breakfast
Assessment by Stroop test
Changes in selective attention at 1 week, according to glycemic index of the breakfast

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2015

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

February 1, 2017

Study Registration Dates

First Submitted

November 19, 2015

First Submitted That Met QC Criteria

November 24, 2015

First Posted (Estimate)

November 26, 2015

Study Record Updates

Last Update Posted (Actual)

March 17, 2017

Last Update Submitted That Met QC Criteria

March 16, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • GRS 1192/B/15

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Control breakfast

3
Subscribe